WHO Model Lists of Essential Medicines: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 23: | Line 23: | ||
*[[Budesonide]] + [[formoterol]] | *[[Budesonide]] + [[formoterol]] | ||
*[[Clarithromycin]] | *[[Clarithromycin]] | ||
*[[Clomipramine]] | |||
*[[Ciprofloxacin]] | *[[Ciprofloxacin]] | ||
*[[Cisplatin]] | *[[Cisplatin]] | ||
| Line 28: | Line 29: | ||
*[[Erlotinib]] | *[[Erlotinib]] | ||
*[[Ethambutol]] | *[[Ethambutol]] | ||
*[[Fluoxetine]] | |||
*[[Formoterol]] | *[[Formoterol]] | ||
*[[Gefitinib]] | *[[Gefitinib]] | ||
| Line 41: | Line 43: | ||
*[[Ribavirin]] | *[[Ribavirin]] | ||
*[[Rituximab]] | *[[Rituximab]] | ||
*[[Sertraline]] | |||
*[[Tamoxifen]] | *[[Tamoxifen]] | ||
*[[Tiotropium bromide]] | *[[Tiotropium bromide]] | ||
*[[Trastuzumab]] | *[[Trastuzumab]] | ||
